3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Pain, Postoperative
9
Pain
5
Neuralgia
5
Breast Neoplasms
5
Agnosia
4
Neoplasms
3
Head and Neck Neoplasms
2
Chronic Pain
2
Visceral Pain
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Seizures
1
Pinealoma
1
Persistent Postoperative Pain
1
Pancreatic Neoplasms
1
Pain, Intractable
1
Oropharyngeal Neoplasms
1
Oligodendroglioma
1
Obesity
1
Neuroectodermal Tumors, Primitive
1
Myotoxicity
1
Mouth Neoplasms
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Follicular
1
Lymphoma
1
Liver Neoplasms
1
Leiomyoma
1
Inflammation
1
Hot Flashes
1
Interventions
Ketamine
4
Oxycodone
2
Gabapentin
2
Diclofenac
2
Anesthesia, General
2
Acetaminophen
2
Transcutaneous Electric Nerve Stimulation
1
Tea
1
Surveys and Questionnaires
1
Ropivacaine
1
Psychotherapy
1
Pregabalin
1
Passive Cutaneous Anaphylaxis
1
Minocycline
1
Meloxicam
1
Lidocaine
1
Ketorolac Tromethamine
1
Ketorolac
1
Ibuprofen
1
Hydromorphone
1
Fentanyl
1
Ethyl Chloride
1
Epinephrine
1
Duloxetine Hydrochloride
1
Diathermy
1
Dexmedetomidine
1
Cryotherapy
1
Control Groups
1
Circumcision, Male
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Acute Pain
×
Pregabalin
×
Clear all
NCT01789216
2021-02-03
PAIN
Major Extremity Trauma Research Consortium
Phase 3
Completed
450 enrolled